Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Effect of clavulanic acid on the minimum inhibitory concentration of benzylpenicillin, ampicillin, carbenicillin, or cephalothin against clinical isolates resistant to beta-lactam antibiotics.

6 in total

1. In vitro study of clavulanic acid in combination with penicillin, amoxycillin, and carbenicillin.

Authors: R Wise; J M Andrews; K A Bedford
Journal: Antimicrob Agents Chemother Date: 1978-03 Impact factor: 5.191

2. Clavulanic acid: a beta-lactamase-inhiting beta-lactam from Streptomyces clavuligerus.

Authors: C Reading; M Cole
Journal: Antimicrob Agents Chemother Date: 1977-05 Impact factor: 5.191

3. Naturally-occurring beta-lactamase inhibitors with antibacterial activity.

Authors: A G Brown; D Butterworth; M Cole; G Hanscomb; J D Hood; C Reading; G N Rolinson
Journal: J Antibiot (Tokyo) Date: 1976-06 Impact factor: 2.649

4. Combined activitiy of clavulanic acid and ticarcillin against ticarcillin-resistant, gram-negative bacilli.

Authors: J W Paisley; J A Washington
Journal: Antimicrob Agents Chemother Date: 1978-08 Impact factor: 5.191

5. Sodium clavulanate potentiation of cephalosporin activity against clinical isolates of cephalothin-resistant Klebsiella pneumoniae.

Authors: R T Jackson; L F Harris; R H Alford
Journal: Antimicrob Agents Chemother Date: 1978-07 Impact factor: 5.191

6. Effect of clavulanic Acid on anaerobic bacteria resistant to Beta-lactam antibiotics.

Authors: J Wüst; T D Wilkins
Journal: Antimicrob Agents Chemother Date: 1978-01 Impact factor: 5.191

6 in total

10 in total

7. In vitro evaluation of Augmentin by broth microdilution and disk diffusion susceptibility testing: regression analysis, tentative interpretive criteria, and quality control limits.

Authors: P C Fuchs; A L Barry; C Thornsberry; T L Gavan; R N Jones
Journal: Antimicrob Agents Chemother Date: 1983-07 Impact factor: 5.191

8. A combination of amoxicillin and clavulanic acid in the treatment of respiratory tract infections caused by amoxicillin-resistant haemophilus influenzae.

Authors: H Beeuwkes; V H Rutgers
Journal: Infection Date: 1981 Impact factor: 3.553

9. Randomized comparative study of amoxicillin-clavulanic acid and co-trimoxazole in the treatment of acute urinary tract infections in adults.

Authors: G N Karachalios
Journal: Antimicrob Agents Chemother Date: 1985-11 Impact factor: 5.191

10. A population model evaluating the consequences of the evolution of double-resistance and tradeoffs on the benefits of two-drug antibiotic treatments.

Authors: Ellsworth M Campbell; Lin Chao
Journal: PLoS One Date: 2014-01-31 Impact factor: 3.240

10 in total

Effect of clavulanic acid on the minimum inhibitory concentration of benzylpenicillin, ampicillin, carbenicillin, or cephalothin against clinical isolates resistant to beta-lactam antibiotics.

1. In vitro study of clavulanic acid in combination with penicillin, amoxycillin, and carbenicillin.

2. Clavulanic acid: a beta-lactamase-inhiting beta-lactam from Streptomyces clavuligerus.

3. Naturally-occurring beta-lactamase inhibitors with antibacterial activity.

4. Combined activitiy of clavulanic acid and ticarcillin against ticarcillin-resistant, gram-negative bacilli.

5. Sodium clavulanate potentiation of cephalosporin activity against clinical isolates of cephalothin-resistant Klebsiella pneumoniae.

6. Effect of clavulanic Acid on anaerobic bacteria resistant to Beta-lactam antibiotics.

1. Bactericidal effects of ticarcillin-clavulanic acid against beta-lactamase-producing bacteria in vivo.

Review 2. Beta-lactamase inhibitors from laboratory to clinic.

3. Activities of amoxicillin and clavulanic acid combinations against urinary tract infections.

4. Clavulanic acid and penicillin treatment of Staphylococcus aureus renal infection in mice.

5. Amoxicillin combined with clavulanic acid for the treatment of soft tissue infections in children.

6. Preparation of novel selenopenams by intramolecular homolytic substitution.

7. In vitro evaluation of Augmentin by broth microdilution and disk diffusion susceptibility testing: regression analysis, tentative interpretive criteria, and quality control limits.

8. A combination of amoxicillin and clavulanic acid in the treatment of respiratory tract infections caused by amoxicillin-resistant haemophilus influenzae.

9. Randomized comparative study of amoxicillin-clavulanic acid and co-trimoxazole in the treatment of acute urinary tract infections in adults.

10. A population model evaluating the consequences of the evolution of double-resistance and tradeoffs on the benefits of two-drug antibiotic treatments.